XML 60 R48.htm IDEA: XBRL DOCUMENT
v3.23.3

Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022
--- | --- | ---
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |
Other | $ 3,042 | $ 3,080
Total accrued expenses and other current liabilities | 19,418 | 14,764
Supply Agreement | Vaxcyte |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |
Collaboration and license agreements and supply agreement accruals | 6,144 | 4,830
CMO |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |
Collaboration and license agreements and supply agreement accruals | 7,428 | 3,900
Clinical Trials |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |
Collaboration and license agreements and supply agreement accruals | $ 2,804 | $ 2,954

X
- Definition Accrued expenses and other current liabilities. + References No definition available. + Details
Name: | stro_AccruedExpensesAndOtherCurrentLiabilities
Namespace Prefix: | stro_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Collaboration and license agreements and supply agreement accruals current. + References No definition available. + Details
Name: | stro_CollaborationAndLicenseAgreementsAndSupplyAgreementAccrualsCurrent
Namespace Prefix: | stro_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_OtherLiabilitiesCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=stro_SupplyAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=stro_VaxcyteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=stro_CmoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=stro_ClinicalTrialsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |